Aortic Valve Stenosis Clinical Trial
— Heart-ROCQOfficial title:
Preventive Heart Rehabilitation in Patients Undergoing Elective Open Heart Surgery to Prevent Complications and to Improve Quality of Life (Heart-ROCQ) - A Prospective Randomized Open Controlled Trial, Blinded End-point (PROBE)
Rationale:
Patients undergoing cardiac surgery are at risk of developing perioperative complications and
major adverse cardiac events, mainly related to both their preoperative status and type of
surgical procedure. Postoperative exercise based cardiac rehabilitation (CR) is an effective
therapy to prolong survival and improve quality of life. However, little is known about the
effect on post-operative complications, quality of life and return to work of a combined pre-
and post-operative CR program encompassing physical therapy, dietary counseling,
psychological support and life style management compared to a CR program, which is provided
only after cardiac surgery.
Objective:
to determine whether a pre- and postoperative (PRE+POST) CR program improves the short (up to
three months) and long term outcomes (up to one year) of the cardiac surgery (i.e. reduction
in postoperative surgical complications, readmissions to hospital and major adverse cardiac
events in conjunction with improvements in the physical component of health related quality
of life), when compared to postoperative CR only (POST).
Study design:
A Prospective Randomized Open controlled trial, Blinded End-point. Patients are randomized
between two standard care CR programs. One group will start a the POST CR program after
surgery. The other group will be randomized to a combined PRE+POST CR program.
Study population:
Patients (age > 18 years) admitted for elective coronary bypass surgery, valve surgery and/or
aortic surgery
Main study parameters/endpoints:
The primary outcome is a composite weighted endpoint of postoperative surgical complications,
re-admissions to hospital, major adverse cardiac events and health related quality of life
(two domains: physical functioning and physical problem), at three months and one year after
surgery. Endpoints are determined by an independent endpoint committee, blinded to the group
allocation. Secondary, the study focuses on physical health (cardiorespiratory fitness,
muscle strength and functional status), psychological health (feelings of anxiety and
depression), work participation, economics, lifestyle risk factors (physical activity and
smoking behavior), self-efficacy and illness representations.
Status | Recruiting |
Enrollment | 350 |
Est. completion date | August 31, 2025 |
Est. primary completion date | August 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients admitted to the department of Thoracic Surgery of the UMCG for: - coronary artery bypass graft surgery - valve surgery - aortic surgery - or a combination of the surgeries mentioned above Exclusion Criteria: - Patients accepted for transcatheter aortic valve implantation (TAVI) - Patients undergoing congenital heart surgery - Aortic descendens or dissections surgery - Elite athletes - Co-morbidities that prevent participation in one or more program elements (e.g. disorders to the nervous or musculoskeletal system that limits exercise capacity, severe COPD (GOLD class 3-4), addiction to alcohol or drugs/ serious psychiatric illness) or when it is undesirable to exercise (e.g. cardiomyopathy/morrow). - Other treatment planned that possibly will interrupt the program (for example on a waiting list for an organ transplantation, preoperative endocarditis or planned chemotherapy for cancer etc.) - Unable to read, write and understand Dutch |
Country | Name | City | State |
---|---|---|---|
Netherlands | University Medical Center Groningen | Groningen |
Lead Sponsor | Collaborator |
---|---|
University Medical Center Groningen |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Illness perception (IPQ-R), | Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery | ||
Other | Cardiac self-efficacy scale (CSA) | Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery | ||
Primary | a composite weighted score of functional status, postoperative surgical complications, re-admissions to hospital and major adverse cardiac events | Each event, complication or worsening in functional status are considered as a score of 1 to 3 points. These points are summed to calculate the total score. | Up to one year post-surgery | |
Secondary | Atrial fibrillation | up to one year post-surgery | ||
Secondary | prolonged stay at the intensive care unit | up to one year post-surgery | ||
Secondary | re-thoracotomy | up to one year post-surgery | ||
Secondary | re-admissions to intensive care unit | up to one year post-surgery | ||
Secondary | re-admissions to hospital | up to one year post-surgery | ||
Secondary | All-cause mortality | up to five year post-surgery | ||
Secondary | six minutes walking test | Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery | ||
Secondary | muscle strength | This will include grip strength and knee extension | Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery | |
Secondary | functional status (KATZ) | Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery | ||
Secondary | Quality of life (Rand-36-v2) | Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery | ||
Secondary | Depression (PHQ-9) | Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery | ||
Secondary | Anxiety (GAD) | Depression (PHQ-9), anxiety (GAD), Quality of life (Rand-36-v2) | Baseline, one day before surgery, 4-7 days, 3-4 months and one year after surgery | |
Secondary | iMTA Productivity Cost Questionnaire (PCQ) | Baseline, 3-4, 7-8 and 12 months post-surgery | ||
Secondary | iMTA Medical Cost Questionnaire (MCQ) | Baseline, 3-4, 7-8 and 12 months post-surgery | ||
Secondary | Lifestyle risk factors | Physical activity is assessed using the Sensewear GECKO mini-armband (SWA) and the long version (27 questions) of the International Physical Activity Questionnaire (iPAQ) | Baseline, 3-4 months and one year post-surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03186339 -
Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI
|
||
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Terminated |
NCT02854319 -
REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System
|
N/A | |
Recruiting |
NCT05601453 -
The ReTAVI Prospective Observational Registry
|
||
Withdrawn |
NCT05481814 -
CPX in Paradoxical Low Flow Aortic Stenosis
|
||
Completed |
NCT02241109 -
Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity
|
N/A | |
Completed |
NCT01700439 -
Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve
|
N/A | |
Recruiting |
NCT04429035 -
SLOW-Slower Progress of caLcificatiOn With Vitamin K2
|
N/A | |
Completed |
NCT04103931 -
Impact of a Patient Decision Aid for Treatment of Aortic Stenosis
|
N/A | |
Completed |
NCT03950440 -
Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement
|
||
Active, not recruiting |
NCT02661451 -
Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
|
N/A | |
Completed |
NCT02792452 -
Clinical Value of Stress Echocardiography in Moderate Aortic Stenosis
|
||
Completed |
NCT02758964 -
Evaluation of Cerebral Thrombembolism After TAVR
|
||
Completed |
NCT02847546 -
Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation
|
N/A | |
Not yet recruiting |
NCT02541877 -
Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve
|
Phase 3 | |
Not yet recruiting |
NCT02536703 -
Safety and Efficacy of Lotus Valve For TAVI In Patients With Severe Aortic Stenosis In Chinese Population
|
Phase 3 | |
Not yet recruiting |
NCT02221921 -
Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI
|
N/A | |
Completed |
NCT02249000 -
BIOVALVE - I / II Clincial Investigation
|
N/A | |
Active, not recruiting |
NCT02080299 -
Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation
|
Phase 2 | |
Terminated |
NCT01939678 -
Characterization and Role of Mutations in Sodium-phosphate Cotransporters in Patients With Calcific Aortic Valve Disease
|